DAXOR CORP — Director's Dealing 2025

Nov 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAXOR CORP (DXR)
CIK: 0000027367
Period of Report: 2025-11-12

Reporting Person: Jefferies John (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-12	Daxor Common Stock	P	2344	—	Acquired	17616	Direct

Footnotes

F1: 2,344 shares granted vest on November 12, 2025.